Related Experiment Video
Updated: Aug 15, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Adult prostate sarcoma: the M. D. Anderson Cancer Center Experience
W J Sexton1, R E Lance, A O Reyes
1Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
The Journal of Urology
|July 18, 2001
Summary
Prostate sarcoma is rare and survival rates are poor. Complete surgical resection and early diagnosis are key for improving outcomes in adult patients with this rare cancer.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Prostate sarcoma is an exceptionally rare malignancy.
- Historically, adult patients diagnosed with prostate sarcoma exhibit poor long-term survival rates.
Purpose of the Study:
- To analyze the institutional experience with prostate sarcoma over three decades.
- To identify prognostic factors influencing survival in adult patients with prostate sarcoma.
Main Methods:
- Retrospective review of 21 adult patients diagnosed with prostate sarcoma.
- Evaluation of presenting symptoms, diagnostic methods, tumor characteristics, and treatment sequences.
- Assessment of clinicopathological variables for prognostic significance.
Main Results:
- Most patients presented with urinary obstruction; diagnosis was typically via biopsy or transurethral resection.
- Leiomyosarcoma was the most common subtype (12/21).
- Negative surgical margins and absence of metastatic disease at presentation were significant predictors of long-term survival (p=0.0005 and p=0.0004, respectively).
Conclusions:
- Adults with prostate sarcoma have a poor disease-specific survival rate.
- Complete surgical resection and early diagnosis represent the most effective strategies for achieving a cure.
